• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

AES-350

CAS No. 847249-57-4

AES-350 ( —— )

产品货号. M24840 CAS No. 847249-57-4

AES-350 是一种有效的口服活性 HDAC6 抑制剂(IC50 和 Ki 分别为 0.0244 μM 和 0.035 μM)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2576 有现货
10MG ¥4277 有现货
25MG ¥7071 有现货
50MG ¥9558 有现货
100MG ¥13122 有现货
500MG ¥26163 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    AES-350
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    AES-350 是一种有效的口服活性 HDAC6 抑制剂(IC50 和 Ki 分别为 0.0244 μM 和 0.035 μM)。
  • 产品描述
    AES-350 is a potent and orally active HDAC6 inhibitor(IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively). It is also against HDAC-3, -8, and -11 in an enzymatic activity assay with IC50 values of 0.187 μM, 0.245 μM, and >1μM, respectively. AES-350 triggers apoptosis in AML cells through HDAC inhibition and can be used for acute myeloid leukemia (AML) research.
  • 体外实验
    In contrast, AES-350 has submicromolar activity (IC50=0.58±0.13 μM) against MV4-11 cells than to that of vorinostat (IC50=0.31±0.061 μM). AES-350 is more ligand efficient and exemplifies a large therapeutic index (IC50>30 μM in noncancerous MRC-9 cells). AES-350 is also shown to be effective in AML-3 (acute myeloid leukemia) cells (IC50=0.73 ± 0.12 μM).AES-350 (0.25-4 μM; 18 hours) induces MV4-11 cells apoptosis in a dose-dependent manner. The late apoptosis ratios are 8.74%, 11.7%,16.08%, 30.97%, and 38.48%, respectively at 0.25 μM-4 μM.An ELISA is performed using HeLa cervical cancer cell lysates, and HeLa cells highly express HDAC6 and are sensitive to AES-350. Correspondingly, ELISA assays depicted a dose-dependent increase in HDAC6 inhibition (IC50=0.58±0.13 μM), Western blot analysis shows that AES-350 (0.1-10 μM) induces a dose-dependent increase in acetylated α-tubulin (Ac-α-tubulin), a substrate of HDAC. Apoptosis Analysis Cell Line:MV4-11 cells Concentration:0.25 μM; 0.5 μM; 1.00 μM; 2.00 μM; 4.00 μM Incubation Time:18 hours Result:Revealed a clear dosedependent increase in the percentage of cells entering late-stage apoptosis, similar to SAHA.
  • 体内实验
    AES-350 (oral gavage; 20 mg/kg; single dose) exhibits a relative good pharmacokinetic (PK) properties in CD-1 mice. The single dose oral bioavailability (F%) of 51 is 19.8%. In comparison, the reported F% for SAHA in mice is significantly lower (8%).
  • 同义词
    ——
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    HDAC
  • 受体
    HDAC11|HDAC3|HDAC6
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    847249-57-4
  • 分子量
    312.36
  • 分子式
    C18H20N2O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:100 mg/mL (320.14 mM; Need ultrasonic)
  • SMILES
    CC(C)(C)C1=CC=C(C(NC2=CC=C(C(NO)=O)C=C2)=O)C=C1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Andrew E Shouksmith, et al. Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.
产品手册
关联产品
  • Alteminostat

    Alteminostat 是一种新型组蛋白脱乙酰酶 (HDAC) 抑制剂。

  • HDAC-IN-52

    HDAC-IN-52 是一种含吡啶的 HDAC 抑制剂,抑制 HDAC1,HDAC2,HDAC3 和 HDAC10 的 IC50 分别为 0.189,0.227,0.440 和 0.446 μM。HDAC-IN-52 可用于癌症研究。

  • Remodelin Fluor

    Remodelin Fluor 是 Remodelin 的小分子类似物,具有抗 NAT10 的体内活性。